Healthcare Industry News: MDS
News Release - November 28, 2013
Sirona Biochem Appoints Nigel Terrett to Board of Directors
VANCOUVER, BRITISH COLUMBIA--(Healthcare Sales & Marketing Network) - November 28, 2013 - Sirona Biochem Corp. (TSX VENTURE:SBM)(OTCQX:SRBCF) announced today the appointment of Nigel Terrett to its Board of Directors."We are thrilled that Nigel Terrett has agreed to join the team," said Neil Belenkie, Chief Executive Officer of Sirona Biochem. "Nigel's background in implementing successful strategic plans in life sciences, and his existing in-depth knowledge of Sirona through his work as our Strategic Advisor, will be an asset to us as we move forward in the growth and expansion of our business."
Sirona Biochem also announces that Chris Verrico will be stepping down from the company's Board of Directors. The company would like to extend its thanks and gratitude for his contribution.
About Nigel Terrett
Nigel Terrett has held many leadership roles in the life sciences sector some of which include his role of Chief Strategic Officer of LifeLabs Inc., Chairman of the Board at Excelleris Technologies, Senior Vice President of MDS Diagnostics Inc., and CIO within MDS Health Group. More recently, Nigel has provided strategic advisory services to the Biotech industry.
Source: Sirona Biochem
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!